Anna Perdrix Rosell

Last updated

Anna Perdrix Rosell
Alma mater
Known forDevelopmental biology, Organoids
AwardsFuture Leaders in Cancer Research Prize, Cancer Research UK
Scientific career
Fields Drug delivery, Tumour growth
Institutions

Anna Perdrix Rosell is a Spanish scientist who completed her PhD[ when? ] in cancer cell signalling at the Francis Crick Institute in London. She co-founded a biotech start-up, which helped her get onto the Forbes 30 under 30 list in 2018. [1] [2]

Contents

Early life and education

Perdrix Rosell grew up in Northern Spain, where she first learned to operate a microscope at the age of 5. Her father owned a company developing pest control methods for agriculture and he and Perdrix Rosell would collect samples to analyse together. [3]

Perdrix Rosell is studying for a PhD in Ilaria Malanchi's lab at the Francis Crick Institute in London and Victoria Sanz-Moreno's lab at King's College London. She studies how cancer cells can signal to other cells around it in the tumour microenvironment, which could potentially help a tumour grow.[ citation needed ]

Research and career

In the second year of her PhD, Perdrix Rosell co-founded a biotech start-up, Sixfold Bioscience, alongside fellow PhD student George Foot and Zuzanna Brzosko, who completed her PhD neuroscience from the University of Cambridge. The company aims to improve the way gene therapies are delivered to cancer cells, using RNA nanotechnology. [4] They use customizable RNA nanoparticles to get drugs into tumours, without harming nearby healthy cells.

Perdrix Rosell said she started the company because “we wanted to build something to deliver cancer drugs only to diseased cells – minimising side effects and increasing the drugs’ efficacy.” [5] The co-founders moved to the US for 3 months at the beginning of 2018 to take the company through the top US accelerator programme, Y Combinator. Sixfold Bioscience secured seed funding from Silicon Valley investors and was short-listed for the first Accelerate@Babraham start-up competition in July 2018. [6] [7]

Perdrix Rosell was picked as the rising star of 2019 in science by The Observer. [3] She also made it onto Forbes 30 under 30 list for European science and healthcare in 2018. [1] [2] [8] [5] [9] And was named 100 Women Founder in Europe to follow on Twitter and LinkedIn. [10]

Related Research Articles

<span class="mw-page-title-main">Francis Crick</span> English physicist, molecular biologist; co-discoverer of the structure of DNA

Francis Harry Compton Crick was an English molecular biologist, biophysicist, and neuroscientist. He, James Watson, Rosalind Franklin, and Maurice Wilkins played crucial roles in deciphering the helical structure of the DNA molecule.

Suzanne Cory is an Australian molecular biologist. She has worked on the genetics of the immune system and cancer and has lobbied her country to invest in science. She is married to fellow scientist Jerry Adams, also a WEHI scientist, whom she met while studying for her PhD at the University of Cambridge, England.

Karen Heather Vousden, CBE, FRS, FRSE, FMedSci is a British medical researcher. She is known for her work on the tumour suppressor protein, p53, and in particular her discovery of the important regulatory role of Mdm2, an attractive target for anti-cancer agents. From 2003 to 2016, she was the director of the Cancer Research UK Beatson Institute in Glasgow, UK, moving back to London in 2016 to take up the role of Chief Scientist at CRUK and Group Leader at the Francis Crick Institute.

<span class="mw-page-title-main">Stephen C. West</span> British biochemist and molecular biologist

Stephen Craig West FRS is a British biochemist and molecular biologist specialising in research on DNA recombination and repair. He is known for pioneering studies on genome instability diseases including cancer. West obtained his BSc in 1974, and his PhD in 1977, both from Newcastle University. He is currently a Principal Group Leader at the Francis Crick Institute in London. He is an honorary Professor at University College London, and at Imperial College London. In recognition of his work he was awarded the Louis-Jeantet Prize for Medicine in 2007, is a fellow of the Royal Society, the Academy of Medical Sciences, an International Member of the National Academy of Sciences, and an International Honorary Member of the American Academy of Arts and Sciences. He received the 2022 Royal Medal for 'discovering and determining the functions of key enzymes that are essential for DNA recombination, repair and the maintenance of genomes'.

<span class="mw-page-title-main">Jennifer Doudna</span> American biochemist and Nobel laureate (born 1964)

Jennifer Anne Doudna is an American biochemist who has done pioneering work in CRISPR gene editing, and made other fundamental contributions in biochemistry and genetics. Doudna was one of the first women to share a Nobel in the sciences. She received the 2020 Nobel Prize in Chemistry, with Emmanuelle Charpentier, "for the development of a method for genome editing." She is the Li Ka Shing Chancellor's Chair Professor in the department of chemistry and the department of molecular and cell biology at the University of California, Berkeley. She has been an investigator with the Howard Hughes Medical Institute since 1997.

<span class="mw-page-title-main">Paula T. Hammond</span> American chemical engineer (born 1963)

Paula Therese Hammond is a David H. Koch Professor in Engineering and the Head of the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT). She was the first woman and person of color appointed as head of the Chemical Engineering department. Her laboratory designs polymers and nanoparticles for drug delivery and energy-related applications including batteries and fuel cells.

<span class="mw-page-title-main">Lucy Shapiro</span> American developmental biologist

Lucy Shapiro is an American developmental biologist. She is a professor of Developmental Biology at the Stanford University School of Medicine. She is the Virginia and D.K. Ludwig Professor of Cancer Research and the director of the Beckman Center for Molecular and Genetic Medicine.

Kathy Niakan is a developmental biologist, working in human developmental and stem cell biology. In 2016 she became the first scientist in the world to gain regulatory approval to edit the genomes of human embryos for research.

<span class="mw-page-title-main">Caroline S. Hill</span>

Caroline Susan Hill is a group leader and head of the Developmental Signalling Laboratory at the Francis Crick Institute.

<span class="mw-page-title-main">Richard Treisman</span> British scientist

Sir Richard Henry Treisman is a British scientist specialising in the molecular biology of cancer. Treisman is a director of research at the Francis Crick Institute in London.

Gregory James Hannon is a professor of molecular cancer biology and director of the Cancer Research UK Cambridge Institute at the University of Cambridge. He is a Fellow of Trinity College, Cambridge while also serving as a director of cancer genomics at the New York Genome Center and an adjunct professor at Cold Spring Harbor Laboratory.

<span class="mw-page-title-main">Charles Swanton</span>

(Robert) Charles Swanton is British physician scientist specialising in oncology and cancer research. Swanton is a senior group leader at London's Francis Crick Institute, Royal Society Napier Professor in Cancer and thoracic medical oncologist at University College London and University College London Hospitals, co-director of the Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, and Chief Clinician of Cancer Research UK.

<span class="mw-page-title-main">Rachel Haurwitz</span> American biochemist

Rachel Elizabeth Haurwitz is an American biochemist and structural biologist. She is the co-founder, chief executive officer, and president of Caribou Biosciences, a genome editing company.

<span class="mw-page-title-main">Sharon Tooze</span>

Sharon Tooze, FMedSci is an American cell biologist who has made significant contributions to the Autophagy field. She is a senior scientist at the Francis Crick Institute and was awarded European Molecular Biology Organization (EMBO) membership in 2010.

<span class="mw-page-title-main">Victoria Cowling</span> English biologist

Victoria Haigh Cowling FRSE is an English biologist who received the Women in Cell Biology Early Career Medal from the British Society for Cell Biology in 2014. Cowling is Professor of Biology, Lister Institute Fellow, MRC Senior Fellow and Deputy Head of The Centre for Gene Regulation and Expression at the University of Dundee.

Janice Chen is co-founder and chief technology officer of Mammoth Biosciences, a Brisbane, California-based company founded in 2018 that is developing diagnostic tests using CRISPR. She received her B.S. degree from Johns Hopkins University and as a graduate student at the University of California, Berkeley, she worked in the lab of CRISPR pioneer Jennifer Doudna, receiving her PhD in Molecular and Cell Biology.

Vivian Li is a Hong Kong-born cell and developmental biologist working in cancer research at London's Francis Crick Institute. She has been researching how stem cells in the human bowel are programmed to ensure a healthy organ and what goes wrong when cancer develops. She is known for her work on the Wnt signalling pathway, discovering a new way that a molecule called Wnt is activated in bowel cancer. She won a Future Leaders in Cancer Research Prize in part for this discovery.

Kathleen Collins is an American biophysicist and professor at the University of California, Berkeley. Her research considers telomerase RNA structure and telomere function. In 2020 she was elected a Fellow of the American Academy of Arts and Sciences.

Samra Turajlic is a medical oncologist and cancer researcher. She leads the cancer dynamics lab at the Francis Crick Institute in London, which focuses on understanding how cancers evolve, as well as working as an oncologist at the Royal Marsden.

Axel Behrens is a German-British molecular biologist and an expert in cancer stem cell biology. He is the Scientific Director of the Cancer Research UK Convergence Science Centre in London, a senior group leader at the Institute of Cancer Research and a professor at Imperial College London.

References